Pooled analysis of DERMIS-1 and DERMIS-2 demonstrated significantly more roflumilast-treated patients achieved Investigator Global Assessment…
Previously reported data demonstrated that roflumilast foam provided statistically significant improvement in disease severity and…
LAVAL, Quebec, March 25, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
Reached new record market share overall adult use market share of 2.06% in February 2022,…
OXFORD, United Kingdom, March 25, 2022 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC) today announced…
Global Phase 2b trial for eblasakimab in moderate-to-severe atopic dermatitis (AD) underway with topline data…
Approval of 36-month shelf life encompasses all ASCENIV & BIVIGAM vial sizes, production scales, as…
BALA CYNWYD, Pa., March 25, 2022 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
This clinical trial, the first-ever oral immunotherapy for patients with mild-to-moderately active Crohn’s Disease, is…
RESEARCH TRIANGLE PARK, N.C., March 25, 2022 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC;…
Calgary, Alberta–(Newsfile Corp. – March 25, 2022) – Sprout AI Inc. (CSE: BYFM) (OTCQB: BYFMF)…
Gotchiverse launching March 31, 2022 Singapore, Singapore–(Newsfile Corp. – March 25, 2022) – Pixelcraft Studios’…
TOKYO, Mar 25, 2022 – (JCN Newswire) – JTOWER Inc. (“JTOWER”) and NTT DOCOMO, INC….
Sydney, Australia, Mar 25, 2022 – (ACN Newswire) – WarSindia, the first Esports-to-earn NFT game…
Seoul, Korea, Mar 25, 2022 – (ACN Newswire) – GONGGANTECH is proud to announce the…
Latest grant to the UNCF rounds out MetLife Foundation’s $5 million commitment to racial equity…
John Linker to Join SSB as Chief Financial Officer, Shoukat Ali Bhamani Named Chief Technology…
The event was just recognized by Choir as one of a cohort of six 2022…
NEW YORK–(BUSINESS WIRE)–fuboTV Inc. (NYSE: FUBO), the leading sports-first live TV streaming platform, announced today…
SAN DIEGO–(BUSINESS WIRE)–$ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a late-stage clinical…